Felodipine Tablet, Extended Release shortage
To Be Discontinued 4 presentations · 1 manufacturers · first FDA posting Oct 7, 2026 · last update Oct 7, 2026
Manufacturers: Par Health, USA LLC
Stated reasons (per FDA): Not stated
More info: FDA Drug Shortages Database · ASHP drug shortages list (search there for this drug)
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Felodipine, Tablet, Extended Release, 2.5 mg (NDC 0603-3581-21) | Par Health, USA LLC | To Be Discontinued | — | Discontinuation in the manufacturing of the drug product | Posted Oct 7, 2026 Updated Oct 7, 2026 Discontinued Oct 1, 2026 |
| Felodipine, Tablet, Extended Release, 2.5 mg (NDC 0603-3581-28) | Par Health, USA LLC | To Be Discontinued | — | Discontinuation in the manufacturing of the drug product | Posted Oct 7, 2026 Updated Oct 7, 2026 Discontinued Oct 1, 2026 |
| Felodipine, Tablet, Extended Release, 5 mg (NDC 0603-3582-21) | Par Health, USA LLC | To Be Discontinued | — | Discontinuation in the manufacturing of the drug product | Posted Oct 7, 2026 Updated Oct 7, 2026 Discontinued Oct 1, 2026 |
| Felodipine, Tablet, Extended Release, 5 mg (NDC 0603-3582-28) | Par Health, USA LLC | To Be Discontinued | — | Discontinuation in the manufacturing of the drug product | Posted Oct 7, 2026 Updated Oct 7, 2026 Discontinued Oct 1, 2026 |